Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway (original) (raw)
- Original Article
- Published: 19 March 2007
- P Guo1,2,
- I Bar-Joseph1,2,
- Y Imanishi1,2,
- M J Jarzynka1,2,
- O Bogler3,
- T Mikkelsen4,
- T Hirose5,
- R Nishikawa6 &
- …
- S Y Cheng1,2
Oncogene volume 26, pages 5577–5586 (2007)Cite this article
- 2338 Accesses
- 155 Citations
- Metrics details
Abstract
Neuropilin-1 (NRP1) functions as a coreceptor through interaction with plexin A1 or vascular endothelial growth factor (VEGF) receptor during neuronal development and angiogenesis. NRP1 potentiates the signaling pathways stimulated by semaphorin 3A and VEGF-A in neuronal and endothelial cells, respectively. In this study, we investigate the role of tumor cell-expressed NRP1 in glioma progression. Analyses of human glioma specimens (WHO grade I–IV tumors) revealed a significant correlation of NRP1 expression with glioma progression. In tumor xenografts, overexpression of NRP1 by U87MG gliomas strongly promoted tumor growth and angiogenesis. Overexpression of NRP1 by U87MG cells stimulated cell survival through the enhancement of autocrine hepatocyte growth factor/scatter factor (HGF/SF)/c-Met signaling. NRP1 not only potentiated the activity of endogenous HGF/SF on glioma cell survival but also enhanced HGF/SF-promoted cell proliferation. Inhibition of HGF/SF, c-Met and NRP1 abrogated NRP1-potentiated autocrine HGF/SF stimulation. Furthermore, increased phosphorylation of c-Met correlated with glioma progression in human glioma biopsies in which NRP1 is upregulated and in U87MG NRP1-overexpressing tumors. Together, these data suggest that tumor cell-expressed NRP1 promotes glioma progression through potentiating the activity of the HGF/SF autocrine c-Met signaling pathway, in addition to enhancing angiogenesis, suggesting a novel mechanism of NRP1 in promoting human glioma progression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
References
- Abounader R, Lal B, Luddy C, Koe G, Davidson B, Rosen EM et al. (2002). In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis. FASEB J 16: 108–110.
Article CAS PubMed Google Scholar - Abounader R, Laterra J . (2005). Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis. Neuro-oncol 7: 436–451.
Article CAS PubMed PubMed Central Google Scholar - Akagi M, Kawaguchi M, Liu W, McCarty MF, Takeda A, Fan F et al. (2003). Induction of neuropilin-1 and vascular endothelial growth factor by epidermal growth factor in human gastric cancer cells. Br J Cancer 88: 796–802.
Article CAS PubMed PubMed Central Google Scholar - Bachelder RE, Lipscomb EA, Lin X, Wendt MA, Chadborn NH, Eickholt BJ et al. (2003). Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res 63: 5230–5233.
CAS PubMed Google Scholar - Bagri A, Tessier-Lavigne M . (2002). Neuropilins as Semaphorin receptors: in vivo functions in neuronal cell migration and axon guidance. Adv Exp Med Biol 515: 13–31.
Article CAS PubMed Google Scholar - Ding H, Wu X, Roncari L, Lau N, Shannon P, Nagy A et al. (2000). Expression and regulation of neuropilin-1 in human astrocytomas. Int J Cancer 88: 584–592.
Article CAS PubMed Google Scholar - Gagnon ML, Bielenberg DR, Gechtman Z, Miao HQ, Takashima S, Soker S et al. (2000). Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: in vivo expression and antitumor activity. Proc Natl Acad Sci USA 97: 2573–2578.
Article CAS PubMed PubMed Central Google Scholar - Gao CF, Vande Woude GF . (2005). HGF/SF-Met signaling in tumor progression. Cell Res 15: 49–51.
Article PubMed Google Scholar - Guo P, Xu L, Pan S, Brekken RA, Yang ST, Whitaker GB et al. (2001). Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites. Cancer Res 61: 8569–8577.
CAS PubMed Google Scholar - Hu B, Guo P, Fang Q, Tao HQ, Wang D, Nagane M et al. (2003). Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2. Proc Natl Acad Sci USA 100: 8904–8909.
Article CAS PubMed PubMed Central Google Scholar - Klagsbrun M, Takashima S, Mamluk R . (2002). The role of neuropilin in vascular and tumor biology. Adv Exp Med Biol 515: 33–48.
Article CAS PubMed Google Scholar - Laterra J, Rosen E, Nam M, Ranganathan S, Fielding K, Johnston P . (1997). Scatter factor/hepatocyte growth factor expression enhances human glioblastoma tumorigenicity and growth. Biochem Biophys Res Commun 235: 743–747.
Article CAS PubMed Google Scholar - Miao HQ, Lee P, Lin H, Soker S, Klagsbrun M . (2000). Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. FASEB J 14: 2532–2539.
Article CAS PubMed Google Scholar - Parikh AA, Fan F, Liu WB, Ahmad SA, Stoeltzing O, Reinmuth N et al. (2004). Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis. Am J Pathol 164: 2139–2151.
Article CAS PubMed PubMed Central Google Scholar - Rieger J, Wick W, Weller M . (2003). Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins. Glia 42: 379–389.
Article PubMed Google Scholar - West DC, Rees CG, Duchesne L, Patey SJ, Terry CJ, Turnbull JE et al. (2005). Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2. J Biol Chem 280: 13457–13464.
Article CAS PubMed Google Scholar - Wey JS, Gray MJ, Fan F, Belcheva A, McCarty MF, Stoeltzing O et al. (2005). Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells. Br J Cancer 93: 233–241.
Article CAS PubMed PubMed Central Google Scholar
Acknowledgements
The work was supported by grants NIH CA102011 and RSG CSM-107144 (S-Y C), the Hillman Fellows Program for Innovative Cancer Research to S-Y C and B H, and grant NIH CA095809 to TM (in part).
Author information
Authors and Affiliations
- University of Pittsburgh Cancer Institute & Department of Pathology, Pittsburgh, PA, USA
B Hu, P Guo, I Bar-Joseph, Y Imanishi, M J Jarzynka & S Y Cheng - Department of Pathology, Research Pavilion at Hillman Cancer Center, Pittsburgh, PA, USA
P Guo, I Bar-Joseph, Y Imanishi, M J Jarzynka & S Y Cheng - Department of Neurosurgery & Brain Tumor Center, MD Anderson Cancer Center, University of Texas, Houston, TX, USA
O Bogler - Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI, USA
T Mikkelsen - Department of Pathology, Saitama Medical University, Saitama, Japan
T Hirose - Department of Neurosurgery, Saitama Medical University, Saitama, Japan
R Nishikawa
Authors
- B Hu
You can also search for this author inPubMed Google Scholar - P Guo
You can also search for this author inPubMed Google Scholar - I Bar-Joseph
You can also search for this author inPubMed Google Scholar - Y Imanishi
You can also search for this author inPubMed Google Scholar - M J Jarzynka
You can also search for this author inPubMed Google Scholar - O Bogler
You can also search for this author inPubMed Google Scholar - T Mikkelsen
You can also search for this author inPubMed Google Scholar - T Hirose
You can also search for this author inPubMed Google Scholar - R Nishikawa
You can also search for this author inPubMed Google Scholar - S Y Cheng
You can also search for this author inPubMed Google Scholar
Corresponding authors
Correspondence toB Hu or S Y Cheng.
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).
Supplementary information
Rights and permissions
About this article
Cite this article
Hu, B., Guo, P., Bar-Joseph, I. et al. Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.Oncogene 26, 5577–5586 (2007). https://doi.org/10.1038/sj.onc.1210348
- Received: 18 September 2006
- Revised: 18 December 2006
- Accepted: 06 January 2007
- Published: 19 March 2007
- Issue Date: 16 August 2007
- DOI: https://doi.org/10.1038/sj.onc.1210348